Abstract
Background: Randomised Controlled Trials show COPD patients have an increased risk of developing pneumonia when prescribed inhaled corticosteroids (ICS), with both aerosol extrafine particle size and ICS-subtype as potential effect modifiers
Original language | English |
---|---|
Publication status | Accepted/In press - 29 Jul 2021 |
Event | ERS International Congress 2021 - Virtual event Duration: 5 Sept 2021 → 8 Sept 2021 https://www.ersnet.org/congress-and-events/congress/ |
Conference
Conference | ERS International Congress 2021 |
---|---|
Abbreviated title | ERS |
Period | 5/09/21 → 8/09/21 |
Internet address |